Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...
No approved drug, clinical-stage asset, or competing research program targets the mechanisms that Liquid's Emerge platform identifies. FRAMINGHAM, MA / ACCESS Newswire / June 9, 2026 / Ignite ...
When doctors and scientists want to see inside a body, magnetic resonance imaging (MRI) is a powerful tool. MRI can noninvasively capture detailed images of the body's muscles, organs, and bones. It ...
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring "youthful" levels of a specific subunit of the telomerase enzyme can significantly ...
1don MSN
Custom protein binders zero in on near-identical disease targets with unprecedented selectivity
In the human body, the boundary between health and severe illness can be microscopic. For decades, molecular scientists have ...
Cells monitor and recycle their proteins through a tightly regulated waste-disposal system. Proteins that are no longer needed are tagged and broken down by specialized cellular machinery. Recent ...
A cancer researcher at the University of Houston is reporting what makes malignant soft tissue cancer grow in children, identifying key mechanisms and molecular targets to prevent tumor progression in ...
A UCLA-led international research collaboration has unveiled a new technology that may help scientists better understand how small molecules, including many drugs, bind to proteins. The invention ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results